PT  - JOURNAL ARTICLE
AU  - K. Kostikas
AU  - G. Papatheodorou
AU  - K. Psathakis
AU  - P. Panagou
AU  - S. Loukides
TI  - Prostaglandin E&lt;sub&gt;2&lt;/sub&gt; in the expired breath condensate of patients with asthma
AID  - 10.1183/09031936.03.00000603
DP  - 2003 Nov 01
TA  - European Respiratory Journal
PG  - 743--747
VI  - 22
IP  - 5
4099  - http://erj.ersjournals.com/content/22/5/743.short
4100  - http://erj.ersjournals.com/content/22/5/743.full
SO  - Eur Respir J2003 Nov 01; 22
AB  - Inhaled prostaglandin (PG)E2 has been found to cause bronchodilation in asthmatics, although it does not have bronchodilative effects in normal subjects. The aim of this study was to investigate the levels of PGE2 in the expired breath condensate of patients with asthma, the possible contribution of smoking habit to its levels and the possible relationship between PGE2 and the degree of bronchial hyperresponsiveness, as assessed by the provocation dose of histamine causing a 20% fall in forced expiratory volume in one second (FEV1) (PD20). A total of 30 mild asthmatics (15 smokers, all steroid-naive, FEV1 88±6 (%±sd)) and 20 healthy control subjects (10 smokers) were studied. Histamine challenge testing was performed in all subjects and the PD20 was determined. The results showed that asthmatic smokers had significantly higher values of PGE2 compared to asthmatic nonsmokers and control subjects (40±21 versus 14.5±4.5 versus 11.7±3 pg·mL−1, respectively). Further analysis showed that PGE2 levels were significantly higher in asthmatic smokers compared to smoker and nonsmoker controls (40±21 versus 11.6±2 versus 11.7±4 pg·mL−1, respectively). No significant difference was observed between asthmatic nonsmokers and both control smokers and control nonsmokers. No significant correlation was found between PGE2 levels and PD20 in all groups of asthmatics, irrespective of smoking habit. In conclusion, the elevation of prostaglandin E2 in the expired breath condensate of patients with asthma is mainly attributed to smoking habit and prostaglandin E2 levels do not predict the degree of bronchial hyperresponsiveness.